CNTA - Centessa Pharmaceuticals plc

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
EPS Growth YoY (%)	-160.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	47.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-10.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	5.0% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	47.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-145.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	7.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-53.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	17.8% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	29.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	11.7% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	4.3% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-26.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	87.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-203.2% Weak ↓ Weak Declining Year-over-year change in net income	40.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-29.0% Weak ↑ Weak Improving Year-over-year change in net income	-14.9% Weak ↑ Weak Improving Year-over-year change in net income	31.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-202.2% Weak ↓ Weak Declining Year-over-year change in net income	-10.1% Weak ↑ Weak Improving Year-over-year change in net income	-76.1% Weak ↓ Weak Declining Year-over-year change in net income	25.0% Good ↓ Good Declining Year-over-year change in net income	14.7% Fair ↓ Fair Declining Year-over-year change in net income	28.3% Excellent ↓ Excellent Declining Year-over-year change in net income	61.5% Excellent ↑ Excellent Improving Year-over-year change in net income	6.9% Fair ↓ Fair Declining Year-over-year change in net income	29.0% Excellent ↓ Excellent Declining Year-over-year change in net income	77.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-56.0% Weak ↑ Weak Improving Year-over-year change in net income	77.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-1749.5% Weak ↑ Weak Improving Year-over-year change in net income	-28692.6% Weak ↓ Weak Declining Year-over-year change in net income	-4900.1% Weak Weak Year-over-year change in net income	-28692.6% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	-9.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-15.3% Weak Weak Year-over-year change in free cash flow	—	—	—	26.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	9.1% Fair Fair Year-over-year change in free cash flow	—	—	-19.6% Weak Weak Year-over-year change in free cash flow	-128.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Operating Margin (%) (%)	—	—	—	—	-205.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1468%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-1.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	49.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	—	—	—	—	-174.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1552%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	-381.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.19x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.27x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.27x Good Good Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Return on Invested Capital (%)	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-84.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-12.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-25.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-12.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-18.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-14.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-8.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-15.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-17.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-14.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-9.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-17.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-12.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-14.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-15.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-12.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-43.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-390%)	-7.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-85.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-671%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Debt to Equity (x)	0.23x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-62%)	0.21x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.36x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-39%)	0.32x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-47%)	0.28x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-53%)	0.27x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-55%)	0.15x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	0.27x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.36x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-41%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.29x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-52%)	0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.24x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	0.21x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	—	—	0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	—	—	—	—	—	—	—
Interest Coverage (x)	-33.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	-30.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-14.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.84x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-41.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-39.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$48.01M	$48.80M	$59.01M	$65.30M	$4.10M	$-274.28M	$-319.33M	$-50.87M	$-41.42M	$-128.03M	$-97.50M	$-71.92M	$-188.39M	$-323.84M	—	—	$-469.67M	$-519.38M	$-578.82M	—	—	$-7.23M	—	—	—
Debt / EBITDA (x)	-1.39x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.61x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.58x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.47x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.63x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.74x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.84x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.56x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.68x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-1.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.11	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.52	$-0.48	$-0.41	$-0.38	$-0.20	$-0.91	$-0.37	$-0.40	$-0.38	$-0.37	$-0.40	$-0.26	$-0.53	$-0.45	$-0.57	$-0.69	$-0.60	$-0.47	$-0.45	$-0.65	$-4.97	—	—	—	—
Free Cash Flow per Share (USD)	$-0.47	—	$-0.44	$-0.17	$-0.43	—	—	—	$-0.37	—	—	—	$-0.50	—	$-0.41	$-0.64	$-0.56	—	—	$-0.53	$-0.24	—	—	—	—
Book Value per Share (USD)	$3.15	$3.53	$2.24	$2.58	$2.89	$3.03	$3.79	$2.54	$2.14	$2.39	$2.66	$2.90	$3.08	$3.54	$3.95	$4.46	$5.11	$5.46	$6.11	$9.22	$5.80	—	—	—	—
Tangible Book Value per Share (USD)	$3.15	$3.53	$2.24	$2.58	$2.89	$3.03	$3.79	$2.54	$2.14	$2.39	$2.66	$2.90	$3.08	$3.54	$3.95	$4.46	$5.11	$5.46	$6.11	$9.22	$5.80	—	—	—	—
Basic Weighted Avg Shares (shares)	153.55M	—	134.16M	133.68M	133.03M	—	116.25M	109.49M	99.89M	—	96.65M	95.16M	94.94M	—	94.33M	94.11M	90.51M	—	89.90M	63.52M	48.05M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Working Capital (USD)	$312.11M	$324.94M	$278.55M	$270.67M	$323.52M	$478.41M	$541.96M	$328.75M	$257.04M	$275.71M	$297.50M	$316.55M	$354.64M	$399.41M	—	—	$554.00M	$604.14M	$582.50M	—	—	$2.55M	—	—	—
LT Debt (USD)	$110.44M	$110.09M	$109.82M	$109.55M	$109.25M	$108.94M	$75.70M	$76.50M	$76.80M	$0.00	$74.00M	$73.30M	$71.60M	$69.80M	—	—	$74.80M	$75.70M	—	—	—	$0.00	—	—	—
Total Equity (USD)	$487.35M	$526.86M	$301.57M	$344.92M	$386.25M	$401.55M	$499.14M	$286.96M	$215.16M	$236.24M	$259.39M	$276.61M	$293.26M	$336.17M	$372.92M	$420.04M	$480.15M	$491.55M	$549.13M	$585.64M	$278.63M	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Jan 29, 2021 10-Q ↗	Q2 FY2020 Jan 29, 2021 10-Q ↗	Q1 FY2020 Jan 29, 2021 10-Q ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$15.00M	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$239.00K	$241.00K	$237.00K	$226.00K	$217.00K	$230.00K	$82.00K	$84.00K	$240.00K	$246.00K	—	—	$89.00K	$36.00K	$35.00K	$32.00K	$28.00K	$12.00K	$15.74K	$7.00K	$2.00K	$0.00	$0.00	$0.00	$0.00
Net Income, GAAP (USD)	$-79.24M	$-66.16M	$-54.89M	$-50.34M	$-26.14M	$-111.33M	$-42.57M	$-43.82M	$-38.05M	$-36.84M	$-38.65M	$-24.89M	$-50.71M	$-43.17M	$-53.88M	$-64.66M	$-54.50M	$-60.77M	$-238.69M	$-41.45M	$-238.69M	$-3.29M	$-829.00K	$-829.00K	$-829.00K
Operating Cash Flow (USD)	$-72.22M	$-55.81M	$-58.31M	$-22.45M	$-57.25M	$-42.80M	—	—	$-37.29M	$-31.05M	—	—	$-47.84M	$-51.56M	$-39.09M	$-59.88M	$-50.02M	$-56.43M	—	$-33.88M	$-11.63M	$-3.28M	$-1.05M	$-1.05M	$-1.05M

Centessa Pharmaceuticals plc

Analytical Summary

25-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CNTA with peers